Journal Specialty Index  

Rheumatology & Allergy

Topic Issue
Desensitisation Therapies for Asthma MAY 2021 ‧ VOL. 13 ‧ NO. 5
Update on the Treatment of Psoriatic Arthritis. What's New in 2021? MARCH 2021 ‧ VOL. 13 ‧ NO. 3
Raynaud's Phenomenon - The Primary-Care Perspective MARCH 2021 ‧ VOL. 13 ‧ NO. 3
COVID-19 Vaccines and Patients With Autoimmune Rheumatic Disease: What Do We Know So Far? MARCH 2021 ‧ VOL. 13 ‧ NO. 3
Monogenic Disorders of Autoimmunity: Targeted Molecular Diagnostics and Treatment in the Era of Precision Medicine MARCH 2021 ‧ VOL. 13 ‧ NO. 3
The Role of Dermatologists in Early Diagnosis and Management of Psoriatic Arthritis in Patients With Psoriasis OCTOBER 2020 ‧ VOL. 12 ‧ NO. 9
Biologic and Targeted Therapies for Rheumatoid Arthritis MARCH 2020 ‧ VOL. 12 ‧ NO. 3
The Management of Hyperuricaemia in Chronic Kidney Disease and Cardiovascular Disorders MARCH 2020 ‧ VOL. 12 ‧ NO. 3
Leukocytoclastic Vasculitis MARCH 2020 ‧ VOL. 12 ‧ NO. 3
Vaccinations in Rheumatic Disease Patients MARCH 2020 ‧ VOL. 12 ‧ NO. 3
Interleukin-23: A Newer Target for Treating Patients with Moderate-to-Severe Psoriasis DECEMBER 2019 ‧ VOL. 11 ‧ NO. 9
New Tricks for the Management of Mild Asthma MAY 2019 ‧ VOL. 11 ‧ NO. 4
The Management of Psoriatic Arthritis MARCH 2019 ‧ VOL. 11 ‧ NO. 2
Inflammatory Myopathies - a Practical Diagnostic Approach MARCH 2019 ‧ VOL. 11 ‧ NO. 2
Immune-related Adverse Event of Cancer Immunotherapy MARCH 2019 ‧ VOL. 11 ‧ NO. 2
Updates on the Use of Biologics in Patients with Psoriasis JANUARY 2019 ‧ VOL. 11 ‧ NO. 1
Disruptions in Medicine: What are the Impacts for Hong Kong? NOVEMBER 2018 ‧ VOL. 10 ‧ NO. 7
Updates on Allergic Diseases: Diagnostic Workup and Pearls on Management SEPTEMBER 2018 ‧ VOL. 10 ‧ NO. 6
Early Diagnosis and Management of Spondyloarthritis MARCH 2018 ‧ VOL. 10 ‧ NO. 2
Diagnosis and Management of Sjogren's Syndrome MARCH 2018 ‧ VOL. 10 ‧ NO. 2
The Use of Glucocorticoids in Rheumatic Diseases MARCH 2018 ‧ VOL. 10 ‧ NO. 2
Behcet's Disease MARCH 2018 ‧ VOL. 10 ‧ NO. 2
Update on Diagnosis and Management of Psoriatic Arthritis NOVEMBER 2017 ‧ VOL. 9 ‧ NO. 7
Comorbidities of Gout APRIL 2017 ‧ VOL. 9 ‧ NO. 3
Updates on the Management of Rheumatoid Arthritis APRIL 2017 ‧ VOL. 9 ‧ NO. 3
Update on the Management of Vasculitides APRIL 2017 ‧ VOL. 9 ‧ NO. 3
Current Understanding of Spondyloarthritis APRIL 2017 ‧ VOL. 9 ‧ NO. 3
Spondyloarthritis: Early Diagnosis and Treatment with Biologics NOVEMBER 2016 ‧ VOL. 8 ‧ NO. 7
Overview of IgG4-related Disease: A Novel Entity JULY 2016 ‧ VOL. 8 ‧ NO. 5
Gout: What is the Treatment Target and How to Achieve the Target? FEBRUARY 2016 ‧ VOL. 8 ‧ NO. 2
Glucocorticoid-induced Osteoporosis FEBRUARY 2016 ‧ VOL. 8 ‧ NO. 2
Role of Musculoskeletal Ultrasound in Diagnosing Arthritis: Insight from New Classification Criteria FEBRUARY 2016 ‧ VOL. 8 ‧ NO. 2
The Era of Biological Therapies in the Management of Psoriasis DECEMBER 2015 ‧ VOL. 7 ‧ NO. 7
Rheumatoid Arthritis and Related Disorders NOVEMBER 2015 ‧ VOL. 7 ‧ NO. 6
Update in the Classification Criteria for Systemic Lupus Erythematous MARCH 2015 ‧ VOL. 7 ‧ NO. 2
Childhood Arthritis: A Review MARCH 2015 ‧ VOL. 7 ‧ NO. 2
The 2010 Rheumatoid Arthritis Classification Criteria MARCH 2015 ‧ VOL. 7 ‧ NO. 2
New Spondyloarthritis Classification Criteria and the Hong Kong Society of Rheumatology Back Pain Referral Guideline MARCH 2015 ‧ VOL. 7 ‧ NO. 2
Biological Therapies in Rheumatic Diseases JANUARY 2015 ‧ VOL. 7 ‧ NO. 1
Overview of Psoriasis for Clinicians NOVEMBER 2014 ‧ VOL. 6 ‧ NO. 7
Glucocorticoid Use in Rheumatology: Mechanism of Action, Adverse Effects and Guidance on Monitoring MARCH 2014 ‧ VOL. 6 ‧ NO. 2
Fibromyalgia MARCH 2014 ‧ VOL. 6 ‧ NO. 2
Immunosuppresants in Systemic Lupus Erythematosus - Treatment Options and Potential Toxicity MARCH 2014 ‧ VOL. 6 ‧ NO. 2
Risks and Benefits of Biologic Agents in Rheumatic Disease MARCH 2014 ‧ VOL. 6 ‧ NO. 2
Selective COX-2 Inhibitors and Non-Selective NSAIDs: A Recap MARCH 2014 ‧ VOL. 6 ‧ NO. 2
Update on Gout Management DECEMBER 2013 ‧ VOL. 5 ‧ NO. 7
Cardiovascular Risk Factors, Morbidity and Mortality in Psoriasis NOVEMBER 2013 ‧ VOL. 5 ‧ NO. 6
Update on Management of Gout and Hyperuricaemia JANUARY 2013 ‧ VOL. 5 ‧ NO. 1
Update on Novel Therapies for Systemic Lupus Erythematosus JANUARY 2013 ‧ VOL. 5 ‧ NO. 1
Update on Treatments in Spondyloarthritis JANUARY 2013 ‧ VOL. 5 ‧ NO. 1
Treat-to-Target in Rheumatoid Arthritis JANUARY 2013 ‧ VOL. 5 ‧ NO. 1
Updates on Systemic Lupus Erythematosus DECEMBER 2012 ‧ VOL. 4 ‧ No. 7
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Clinical Update and Literature Review NOVEMBER 2012 ‧ VOL. 4 ‧ NO. 6
Rheumatoid Arthritis: Advances in Therapeutics MARCH 2012 ‧ VOL. 4 ‧ NO. 2
The Challenge and Essence of the Management of Psoriasis MARCH 2012 ‧ VOL. 4 ‧ NO. 2
Cardiovascular Risk in Patients With Psoriatic Arthritis JANUARY 2012 ‧ VOL. 4 ‧ NO. 1
Safety of Biologic Agents in Inflammatory Diseases DECEMBER 2011 ‧ VOL. 3 ‧ NO. 7
Medical Treatment of Ankylosing Spondylitis JULY 2010 ‧ VOL. 2 ‧ NO. 4
Era of Biologics: Therapeutic Strategies for Rheumatoid Arthritis JULY 2009 ‧ VOL. 1 ‧ NO. 3